NeuroVive completes rights offering

NeuroVive Pharmaceutical AB (SSE:NVP), Lund, Sweden Business: Neurology Date completed: 1/31/14 Type: Rights offering Raised: SEK85.8 million ($13.1 million) Shares: 6.1 million Price: SEK14 Shares af...